BiochemistrybioRxivPreprint
Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors
M. L. Bobby, D. Fearon, M. Ferla…·F. von Delft
The paper describes an open-science drug discovery campaign that identified a non-covalent, non-peptidic inhibitor of SARS-CoV-2 main protease using crowdsourcing and computational methods.
DOI 10.1101/2020.10.29.339317